Spleen Tyrosine Kinase (Syk) Inhibitor Therapeutics
Spleen Tyrosine Kinase (Syk) inhibitors are a class of small-molecule targeted therapies that block the activity of Syk, an intracellular enzyme involved in immune cell signaling. These drugs are mainly investigated or used for autoimmune, inflammatory, and hematologic conditions.
Syk plays a central role in transmitting signals from immune receptors, especially in B cells, mast cells, and macrophages.
What is Syk?
Syk (Spleen Tyrosine Kinase) is a non-receptor tyrosine kinase involved in:
B-cell receptor (BCR) signaling
Fc receptor signaling (IgG, IgE mediated responses)
Activation of inflammatory immune cells
2 visualizações
